Jenome Biophar

Delhi, India Founded: 2014 • Age: 12 yrs
Offers comprehensive drug development services for biopharmaceutical needs.
Annual revenue $923,994 Latest available
Total funding - Funding intelligence
Employees 1 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Jenome Biophar

Jenome Biophar is a company based in Delhi (India) founded in 2014. It operates as a B2B. The company has 1 employees as of March 31, 2022. Jenome Biophar operates in a competitive market with competitors including Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm, Ocelot Bio and Aperiam Bio, among others.

  • Headquarter Delhi, India
  • Employees 1 as on 31 Mar, 2022
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Jenome Biophar Private Limited
  • Date of Incorporation 28 Jan, 2014
  • Jurisdiction New Delhi, Delhi, India
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $923.99 K (USD)
    2.61
    as on Mar 31, 2022
  • Net Profit
    $25.19 K (USD)
    124.67
    as on Mar 31, 2022
  • EBITDA
    $144.23 K (USD)
    354.2
    as on Mar 31, 2022
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    1

    as on Mar 31, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Jenome Biophar

Premium access

Detailed funding history for Jenome Biophar

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Jenome Biophar

Investments
Premium access

Investment portfolio details for Jenome Biophar

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Jenome Biophar

Premium access

Detailed financials for Jenome Biophar

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Jenome Biophar Comparisons

Jenome Biophar Primary company
Description
Offers comprehensive drug development services for biopharma...
Location
Delhi, India
Founded Year
2014
Annual Revenue
$923.99 K (USD)
Net Profit
$25.19 K (USD)
EBITDA
$144.23 K (USD)
Employees
1
As of 2022
Premium access

Peer comparison for Jenome Biophar

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Jenome Biophar

Jenome Biophar operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm, Ocelot Bio and Aperiam Bio, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Company specializing in development of Biosimilars
Locked Locked Locked
Polypeptide drugs and APIs are developed and manufactured.
Locked Locked Locked
CDMO and analytical services for peptide development are provided.
Locked Locked Locked
Ocelot Bio is a CDMO specializing in peptide manufacturing services.
Locked Locked Locked
Industrial and therapeutic proteins are manufactured by Aperiam Bio.
Locked Locked Locked
Proprietary, GMP-grade, and non-GMP peptides are manufactured by PolyPeptide Labs.
Premium access

Detailed competitors of Jenome Biophar

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Jenome Biophar

Premium access

Complete news archive for Jenome Biophar

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jenome Biophar

Jenome Biophar was founded in 2014.

Jenome Biophar is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

As of Mar 31, 2022, the latest employee count at Jenome Biophar is 1.

Annual revenue of Jenome Biophar is $923.99K as on Mar 31, 2022.

Jenome Biophar offers comprehensive drug development services for biopharmaceutical needs through providing healthcare solutions, biopharmaceuticals, drug development, and research services. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Jenome Biophar's top competitors include Enzene Biosciences, Hybio Pharmaceutical and PolyPeptide.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available